News
Japanese drugmaker Eisai today revealed that it has launched its Urece (dotinurad) in China as a treatment for gout. Urece ...
Even as the US Food and Drug Administration (FDA) has unveiled a strategic expansion of its oversight mechanisms for foreign ...
South Korea’s Samsung Bioepis today published a whitepaper titled ‘Solving the Biosimilar Void in Europe’ that proposes ...
New figures in Danish pharma trade group Lif's Medicine Reimbursement Meter show a slight increase in the number of pharmacy ...
US biotech Crinetics Pharmaceuticals (Nasdaq: CRNX) has released new data on its investigational oral therapy Palsonify (paltusotine), supporting its potential as a convenient alternative to monthly ...
Ultragenyx Pharmaceutical (Nasdaq: RARE) has been dealt a regulatory setback, as the American medicines regulator has ...
The US Food and Drug Administration (FDA) last week authorized KalVista Pharmaceutical’s Ekterly for the treatment of acute ...
Data presented on the EURneffy/neffy adrenaline (epinephrine) nasal spray at the European Academy of Allergy & Clinical ...
A significant advancement in weight management has arrived for Singaporeans. Danish pharma Novo Nordisk has announced the ...
Ireland-based biopharma Jazz Pharmaceuticals has been called out for a couple of indiscretions by The Prescription Medicines Code of Practice Authority (PMCPA), which was established by the ...
CSL Seqirus, a subsidiary of Australia’s CSL Limited, said it has commenced shipping its differentiated portfolio of ...
US biotech Capricor Therapeutics today revealed receipt of a Complete Response Letter (CRL) from the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results